Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.
Anna DobrutMonika Brzychczy-WłochPublished in: Pathogens (Basel, Switzerland) (2021)
Streptococcus agalactiae (Group B Streptococcus, GBS) is an opportunistic pathogen, which asymptomatically colonizes the gastrointestinal and genitourinary tract of up to one third of healthy adults. Nevertheless, GBS carriage in pregnant women may lead to several health issues in newborns causing life threatening infection, such as sepsis, pneumonia or meningitis. Recommended GBS screening in pregnant women significantly reduced morbidity and mortality in infants. Nevertheless, intrapartum antibiotic prophylaxis, recommended following the detection of carriage or in case of lack of a carriage test result for pregnant women who demonstrate certain risk factors, led to the expansion of the adverse phenomenon of bacterial resistance to antibiotics. In our paper, we reviewed some immunogenic GBS proteins, i.e., Alp family proteins, β protein, Lmb, Sip, BibA, FsbA, ScpB, enolase, elongation factor Tu, IMPDH, and GroEL, which possess features characteristic of good candidates for immunodiagnostic assays for GBS carriage detection, such as immunoreactivity and specificity. We assume that they can be used as an alternative diagnostic method to the presently recommended bacteriological cultivation and MALDI.
Keyphrases
- pregnant women
- candida albicans
- risk factors
- biofilm formation
- loop mediated isothermal amplification
- healthcare
- label free
- public health
- pregnancy outcomes
- mass spectrometry
- acute kidney injury
- emergency department
- escherichia coli
- pseudomonas aeruginosa
- dendritic cells
- small molecule
- preterm infants
- immune response
- low birth weight
- extracorporeal membrane oxygenation
- social media
- quantum dots
- health promotion